The Rise of Agentic AI in Drug Design

​The event will bring together leading voices from biotech, pharma, AI, quantum, venture, and enterprise technology to explore how intelligent computational systems are changing the way we discover, design, and scale new therapeutics. What is required to turn frontier science into platforms that can transform industry? The challenges will be framed by senior pharma R&D leader and drug hunter David Barrett, with additional talks and perspectives from leading London techbio and biotech companies.